John T. Treace, Chief Executive Officer at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 120,390 shares at $16.09 ($1.9M) on 2021-12-21, disclosed to the SEC on 2021-12-22.
Open-market sale of $1.9M TMCI by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.74 | 22,311 | $351K | 18.3% |
| 2 | $15.74 | 22,311 | $351K | 18.3% |
| 3 | $16.31 | 600 | $10K | 0.5% |
| 4 | $16.09 | 34,047 | $548K | 28.5% |
| 5 | $16.09 | 34,047 | $548K | 28.5% |
| 6 | $16.37 | 3,537 |
| $58K |
| 3.0% |
| 7 | $16.37 | 3,537 | $58K | 3.0% |
| Total | $15.98 avg | 120,390 | $1.9M | 100% |
| Filing → |
| TMCI | BUY | 2026-06-11 | $211K | — | Filing → |
| TMCI | BUY | 2026-06-01 | $178K | — | Filing → |
| TMCI | BUY | 2026-05-28 | $341K | — | Filing → |